[{"address1": "500 West 5th Street", "address2": "Suite 1200", "city": "Austin", "state": "TX", "zip": "78701", "country": "United States", "phone": "512 900 4690", "website": "https://www.shattucklabs.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.", "fullTimeEmployees": 75, "companyOfficers": [{"maxAge": 1, "name": "Dr. Taylor H. Schreiber M.D., Ph.D.", "age": 43, "title": "Co-Founder, CEO & Director", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 792885, "exercisedValue": 0, "unexercisedValue": 357187}, {"maxAge": 1, "name": "Mr. Andrew R. Neill M.B.A.", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 603956, "exercisedValue": 0, "unexercisedValue": 496087}, {"maxAge": 1, "name": "Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.", "age": 64, "title": "Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 695243, "exercisedValue": 0, "unexercisedValue": 434807}, {"maxAge": 1, "name": "Dr. Abhinav A. Shukla Ph.D.", "age": 50, "title": "Chief Technical Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 567398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Conor  Richardson CPA", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Stout J.D., Ph.D.", "age": 48, "title": "General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Casi  DeYoung", "age": 52, "title": "Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 523482, "exercisedValue": 0, "unexercisedValue": 493071}, {"maxAge": 1, "name": "Dr. Thomas  Lampkin Pharm.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Fromm Ph.D.", "title": "Chief Scientific Officer of ARC Platform", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh de Silva Ph.D.", "title": "Chief Scientific Officer of GADLEN Platform", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1727740800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.26, "open": 1.22, "dayLow": 1.2104, "dayHigh": 1.53, "regularMarketPreviousClose": 1.26, "regularMarketOpen": 1.22, "regularMarketDayLow": 1.2104, "regularMarketDayHigh": 1.53, "beta": 1.732, "forwardPE": -1.3084111, "volume": 2043654, "regularMarketVolume": 2043654, "averageVolume": 555492, "averageVolume10days": 2311440, "averageDailyVolume10Day": 2311440, "bid": 1.39, "ask": 1.42, "bidSize": 300, "askSize": 300, "marketCap": 66818220, "fiftyTwoWeekLow": 1.07, "fiftyTwoWeekHigh": 11.76, "priceToSalesTrailing12Months": 16.202284, "fiftyDayAverage": 3.2022, "twoHundredDayAverage": 6.765825, "currency": "USD", "enterpriseValue": -34706824, "floatShares": 27667498, "sharesOutstanding": 47727300, "sharesShort": 5486108, "sharesShortPriorMonth": 5313921, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.1149, "heldPercentInsiders": 0.13337, "heldPercentInstitutions": 0.73334, "shortRatio": 36.16, "shortPercentOfFloat": 0.1727, "bookValue": 2.318, "priceToBook": 0.6039689, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -85284000, "trailingEps": -1.85, "forwardEps": -1.07, "enterpriseToRevenue": -8.416, "enterpriseToEbitda": 0.402, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "STTK", "underlyingSymbol": "STTK", "shortName": "Shattuck Labs, Inc.", "longName": "Shattuck Labs, Inc.", "firstTradeDateEpochUtc": 1602250200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "64a83d67-d0cd-3885-8206-d0f94edae33a", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.4, "targetHighPrice": 2.0, "targetLowPrice": 2.0, "targetMeanPrice": 2.0, "targetMedianPrice": 2.0, "recommendationMean": 2.6, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 105344000, "totalCashPerShare": 2.207, "ebitda": -86318000, "totalDebt": 3819000, "quickRatio": 7.011, "currentRatio": 7.615, "totalRevenue": 4124000, "debtToEquity": 3.452, "revenuePerShare": 0.088, "returnOnAssets": -0.39741, "returnOnEquity": -0.68481004, "freeCashflow": -31852376, "operatingCashflow": -63230000, "revenueGrowth": 7.045, "operatingMargins": -14.27098, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-10"}]